The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure

Chest

Volumn 110, Issue 2, 1996, Pages 325-332

  Cahalin, Lawrence P ^a   Mathier, Michael A ^a   Semigran, Marc J ^a   Dec, G William ^a   DiSalvo, Thomas G ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

6 min walk test; cardiac transplantation; cardiopulmonary exercise testing; heart failure

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC VALUE; EXERCISE TEST; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; OXYGEN CONSUMPTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; WALKING;

EID: 0029758959     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.2.325     Document Type: Article

References (31)

1. Armstrong PW, Moe GW. Medical advances in the therapy of congestive heart failure. Circulation 1993; 88:2941-52
2. Australian-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995; 92:212-18
3. Sveta CA. Gheorgihiade M, Adams KF, et al. Safety and efficacy of epoprostenol in patients with severe congestive heart failure: epoprostenol multicenter research group. Am J Cardiol 1995; 75:34-41
4. Provenier F, Jordoens S. Evaluation of 6-minute walking test in patients with single chamber rate response pacers. Br Heart J 1994; 72:192-6
5. Bittner V, Weiner DH, Yusuf S, et al. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270:1702-07
6. Lipkin DP, Scriben AJ, Crake T, et al. Six-minute walking test for assessing exercise capacity in chronic heart failure. BMJ 1988; 292:653-55
7. Guyatt GH, Sullivan MJ, Thompson PJ, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 1985; 132:919-23
8. Guyatt GH, Pugsley SO, Sullivan MJ, et al. Effect of encouragement on walking test performance. Thorax 1984; 39:818-22
9. Szlacheic J, Massic BM, Kramer BL, et al. Correlates and prognostic implications of exercise capacity in chronic congestive heart failure. Am J Cardiol 1985; 55:1037-42
10. Cohn JN, Rector TS. Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 1988; 62:25A-30A
11. Willens HJ, Blevins RD, Wrisley D, et al. The prognostic value of functional capacity in patients with mild to moderate heart failure. Am Heart J 1987; 114:377-82
12. Cohn JN, Archibald DG, Francis GS, et al. Veterans Administration Cooperarion Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate. Circulation. 1987; 75(suppl 4):49-63
13. Griffin BP, Shah PK, Ferguson J, et al. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy. Am J Cardiol 1991; 67:848-53
14. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol 1987; 59:634-38
15. Pilote L, Silberberg J, Lisbona R, et al. Prognosis in patients with low left ventricular ejection fraction after myocardial infarction: importance of exercise capacity. Circulation 1989; 80:1636-41
16. Mancini DM, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991; 83:778-86
17. Di Salvo T, Mathier M, Semigran M, et al. Preserved right ventricular ejection fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll Cardiol 1995; 25:1143-53
18. American Thoracic Society. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987; 136:1285-89
19. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123:659-64
20. Cotes JE. Lung function assessment and application in medicine. 4th ed. Oxford: Blackwell Scientific Publications, 1979: 1-604
21. Kaul S, Boucher CA, Okada RD, et al. Sources of variability in the radionuclide angiographic assessment of ejection fraction. Am J Cardiol 1984; 53:823-28
22. Borg G. Psychophysical basis of perceived exertion. Med Sci Sports Exerc 1982; 14:377-81
23. Borg G, Ottoson D. The perception of exertion in physical work. London: Macmillan Press, 1986
24. McGavin CF, Gupta SP, McHardy GJR. Twelve-minute walking test for assessing disability in chronic bronchitis. BMJ 1976; 1:822-23
25. Carlson DJ, Ries AL, Kaplan RM. Prediction of maximum exercise tolerance in patients with COPD. Chest 1991; 100:307-11
26. Kraemer MD, Kubo SH, Rector TS, et al. Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure. J Am Coll Cardiol 1993; 21:641-48
27. Wright RS, Levine MS, Bellamy PE, et al. Ventilatory and diffusion abnormalities in potential heart transplant recipients. Chest 1990; 98:816-20
28. Cahalin L, Prevost S, Pappas P, et al. The relationship of the 6-minute walk test to maximal oxygen consumption in end-stage lung disease. Chest 1993; 104:151S
29. Langenfeld H, Schneider B, Grimm W, et al. The 6-minute walk - an adequate exercise test for pacemaker patients? PACE 1990; 13:1761-5
30. Rozkovec A, Papouchado M, James MA, et al. The relationship of symptoms to performance in paced patients with breathlessness. Eur Heart J 1989; 10:63-9
31. Myers J, Buchanan N, Walsh D, et al. Comparison of the ramp versus standard exercise protocols. J Am Coll Cardiol 1991; 17:1.334-42